TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

THERATECHNOLOGIES

ImmunologyInfectious DiseaseOncology
Biotech

THERATECHNOLOGIES is a biotechnology company focused on Immunology, Infectious Disease, Oncology.

2010
Since
2
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 43%
1 drugs
Infectious Disease 43%
1 drugs
Oncology 7%
0 drugs Phase 1: 1
Metabolic 7%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...